The EXTEND-IA TNK trial suggesting better outcomes with tenecteplase than alteplase in the treatment of acute ischemic stroke has now been published in the New England Journal of Medicine.
Medscape Medical News
Original Article: Tenecteplase: Thrombolytic of Choice in Stroke?